EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 370 filers reported holding EXELIXIS INC in Q3 2020. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,488,578 | +26.4% | 2,266,932 | +10.7% | 0.02% | +33.3% |
| Q2 2023 | $39,152,082 | -11.6% | 2,048,175 | -10.3% | 0.01% | -20.0% |
| Q1 2023 | $44,299,913 | +14.2% | 2,282,324 | -5.6% | 0.02% | +15.4% |
| Q4 2022 | $38,779,000 | -0.8% | 2,417,720 | -3.0% | 0.01% | -7.1% |
| Q3 2022 | $39,075,000 | -0.4% | 2,492,105 | +32.2% | 0.01% | 0.0% |
| Q2 2022 | $39,251,000 | -25.9% | 1,885,236 | -19.3% | 0.01% | -12.5% |
| Q1 2022 | $52,957,000 | +45.9% | 2,335,978 | +17.6% | 0.02% | +60.0% |
| Q4 2021 | $36,296,000 | +251.0% | 1,985,541 | +305.9% | 0.01% | +233.3% |
| Q3 2021 | $10,340,000 | -19.6% | 489,164 | -30.7% | 0.00% | -25.0% |
| Q2 2021 | $12,857,000 | -20.1% | 705,512 | -0.9% | 0.00% | -20.0% |
| Q1 2021 | $16,083,000 | +0.9% | 711,937 | -10.3% | 0.01% | -16.7% |
| Q4 2020 | $15,932,000 | -10.1% | 793,838 | +9.5% | 0.01% | -14.3% |
| Q3 2020 | $17,728,000 | -20.0% | 725,042 | -22.4% | 0.01% | -22.2% |
| Q2 2020 | $22,169,000 | +66.2% | 933,858 | +20.5% | 0.01% | +28.6% |
| Q1 2020 | $13,335,000 | +2.4% | 774,688 | +4.8% | 0.01% | +40.0% |
| Q4 2019 | $13,025,000 | -12.6% | 739,225 | -12.3% | 0.01% | -28.6% |
| Q3 2019 | $14,901,000 | -21.3% | 842,555 | -4.9% | 0.01% | -12.5% |
| Q2 2019 | $18,929,000 | -3.2% | 885,695 | +7.7% | 0.01% | -11.1% |
| Q1 2019 | $19,563,000 | +20.3% | 822,020 | -0.6% | 0.01% | +12.5% |
| Q4 2018 | $16,264,000 | +5.8% | 826,879 | -4.7% | 0.01% | +60.0% |
| Q3 2018 | $15,368,000 | +580.6% | 867,215 | +726.7% | 0.01% | +400.0% |
| Q2 2018 | $2,258,000 | -44.5% | 104,902 | -43.0% | 0.00% | -50.0% |
| Q1 2018 | $4,068,000 | -14.4% | 183,987 | +17.7% | 0.00% | 0.0% |
| Q4 2017 | $4,751,000 | +166.9% | 156,258 | +112.8% | 0.00% | +100.0% |
| Q3 2017 | $1,780,000 | -67.8% | 73,446 | -67.2% | 0.00% | -66.7% |
| Q2 2017 | $5,520,000 | -35.8% | 224,136 | -43.5% | 0.00% | -25.0% |
| Q1 2017 | $8,601,000 | +52.3% | 396,970 | +4.8% | 0.00% | +33.3% |
| Q4 2016 | $5,647,000 | +8.1% | 378,778 | -7.2% | 0.00% | 0.0% |
| Q3 2016 | $5,223,000 | +172.6% | 408,324 | +66.4% | 0.00% | +200.0% |
| Q2 2016 | $1,916,000 | +156.5% | 245,321 | +85.3% | 0.00% | – |
| Q4 2015 | $747,000 | -25.9% | 132,410 | -26.3% | 0.00% | -100.0% |
| Q3 2015 | $1,008,000 | +20060.0% | 179,656 | +5888.5% | 0.00% | – |
| Q3 2014 | $5,000 | -44.4% | 3,000 | +7.7% | 0.00% | – |
| Q2 2014 | $9,000 | +28.6% | 2,785 | +50.9% | 0.00% | – |
| Q1 2014 | $7,000 | -36.4% | 1,845 | 0.0% | 0.00% | – |
| Q4 2013 | $11,000 | -86.1% | 1,845 | -86.4% | 0.00% | – |
| Q3 2013 | $79,000 | +31.7% | 13,559 | +1.9% | 0.00% | – |
| Q2 2013 | $60,000 | – | 13,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |